Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 24, 2019

SELL
$18.19 - $31.79 $158,616 - $277,208
-8,720 Closed
0 $0
Q2 2018

Jul 26, 2018

BUY
$31.4 - $41.01 $273,808 - $357,607
8,720 New
8,720 $312,000
Q1 2018

Apr 30, 2018

SELL
$29.84 - $44.08 $478,036 - $706,161
-16,020 Closed
0 $0
Q4 2017

Jan 26, 2018

BUY
$21.89 - $31.34 $350,677 - $502,066
16,020
16,020 $492,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $87.3M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.